| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.25 | 6e-08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.26 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |